Biomerica (BMRA) Net Margin Growth (1y) (2011 - 2026)
Biomerica (BMRA) Net Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -860.00 |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 469.00 |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 94.00 |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 92.00 |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | -777.00 |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 350.00 |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 85.00 |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -81.00 |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 67.00 |
| 10 | Biomerica | 4.85 Mn | 3.51 Mn | -44,000.00 | -2,900.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -2,900.00 |
| Nov 30, 2025 | -5,102.00 |
| Aug 31, 2025 | 7,297.00 |
| May 31, 2025 | -9,557.00 |
| Feb 28, 2025 | 8,466.00 |
| Nov 30, 2024 | 3,810.00 |
| Aug 31, 2024 | -674.00 |
| May 31, 2024 | 9,944.00 |
| Feb 29, 2024 | -4,008.00 |
| Nov 30, 2023 | 1,355.00 |
| Aug 31, 2023 | 6,049.00 |
| May 31, 2023 | -17,657.00 |
| Feb 28, 2023 | -14,716.00 |
| Nov 30, 2022 | -8,550.00 |
| Aug 31, 2022 | -434.00 |
| May 31, 2022 | 27,603.00 |
| Feb 28, 2022 | 5,718.00 |
| Nov 30, 2021 | 10,096.00 |
| Aug 31, 2021 | 4,321.00 |
| May 31, 2021 | -27,922.00 |